Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

9.925 +0.545 (+5.81%)
Streaming Delayed Price Updated: 3:01 PM EDT, Sep 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ADMA Biologics Inc - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
Forecasting The Future: 4 Analyst Projections For ADMA Biologics ↗
 
Via Benzinga
News headline image
Recap: ADMA Biologics Q4 Earnings ↗
 
Via Benzinga
News headline image
ADMA Biologics Announces CFO Transition
Executive Search Initiated for CFO Replacement 
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Earnings Preview For ADMA Biologics ↗
 
Via Benzinga
News headline image
Cracking The Code: Understanding Analyst Reviews For ADMA Biologics ↗
 
Via Benzinga
News headline image
Earnings Preview: ADMA Biologics ↗
 
Via Benzinga
News headline image
Preview: ADMA Biologics's Earnings ↗
 
Via Benzinga
News headline image
Recap: ADMA Biologics Q1 Earnings ↗
 
Via Benzinga
News headline image
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Conference Call Scheduled for February 28, 2024, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
A Preview Of ADMA Biologics's Earnings ↗
 
Via Benzinga
News headline image
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Why Adma Biologics Stock Crushed the Market on Friday ↗
The network of FDA-approved collection facilities continues to grow. 
Via The Motley Fool
News headline image
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
FDA Approval Signifies the Accomplishment of ADMA’s Corporate Goal of Plasma Supply Self-Sufficiency 
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Why Adma Biologics Was Trouncing the Market Today ↗
The company beat analyst estimates for both revenue and profitability, and raised revenue guidance. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
Conference Call Scheduled for November 8, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Why Shares of ADMA Biologics Are Climbing Thursday ↗
The company, which focuses on infectious diseases, reported its second-quarter earnings on Wednesday after the markets closed. 
Via The Motley Fool
News headline image
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
Conference Call Scheduled for August 9, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
Conference Call Scheduled for May 10, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Amendment to Credit Agreement
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50. 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.